A vaccine for hypertension.
Ménard
Joël
J
D000804:Angiotensin II / Q000276:immunology*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D035843:Biomedical Research / Q000941:ethics; D002986:Clinical Trials as Topic / Q000941:ethics; D049673:History, 20th Century; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000266:history / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000276:immunology; D014612:Vaccines / Q000266:history / Q000627:therapeutic use*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D014612:Vaccines; D000804:Angiotensin II